These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 9152289)

  • 1. Contribution of growth hormone deficiency to the growth failure that follows bone marrow transplantation.
    Brauner R; Adan L; Souberbielle JC; Esperou H; Michon J; Devergie A; Gluckman E; Zucker JM
    J Pediatr; 1997 May; 130(5):785-92. PubMed ID: 9152289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth, growth hormone and final height after BMT. Possible recovery of irradiation-induced growth hormone insufficiency.
    Holm K; Nysom K; Rasmussen MH; Hertz H; Jacobsen N; Skakkebaek NE; Krabbe S; Müller J
    Bone Marrow Transplant; 1996 Jul; 18(1):163-70. PubMed ID: 8832010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure to increase insulin-like growth factor-I synthesis is involved in the mechanisms of growth retardation of children with inherited liver disorders.
    Maghnie M; Barreca A; Ventura M; Tinelli C; Ponzani P; De Giacomo C; Maggiore G; Severi F
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):747-55. PubMed ID: 9713564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in height, weight and plasma leptin after bone marrow transplantation.
    Couto-Silva AC; Trivin C; Esperou H; Michon J; Fischer A; Brauner R
    Bone Marrow Transplant; 2000 Dec; 26(11):1205-10. PubMed ID: 11149732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth and growth hormone secretion after bone marrow transplantation.
    Brauner R; Fontoura M; Zucker JM; Devergie A; Souberbielle JC; Prevot-Saucet C; Michon J; Gluckman E; Griscelli C; Fischer A
    Arch Dis Child; 1993 Apr; 68(4):458-63. PubMed ID: 8503666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone.
    Giorgiani G; Bozzola M; Locatelli F; Picco P; Zecca M; Cisternino M; Dallorso S; Bonetti F; Dini G; Borrone C
    Blood; 1995 Jul; 86(2):825-31. PubMed ID: 7606014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.
    Tillmann V; Patel L; Gill MS; Whatmore AJ; Price DA; Kibirige MS; Wales JK; Clayton PE
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):329-36. PubMed ID: 10971450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone function and treatment following bone marrow transplant for neuroblastoma.
    Olshan JS; Willi SM; Gruccio D; Moshang T
    Bone Marrow Transplant; 1993 Oct; 12(4):381-5. PubMed ID: 8275038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of insulin-like binding protein-2 in prepubertal short children and its diagnostic value in the evaluation of growth hormone deficiency.
    van Doorn J; Ringeling AM; Rikken B; van Buul-Offers SC
    Horm Res; 2001; 55(3):147-54. PubMed ID: 11549877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth in children after bone marrow transplantation for acute leukemia.
    Huma Z; Boulad F; Black P; Heller G; Sklar C
    Blood; 1995 Jul; 86(2):819-24. PubMed ID: 7606013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) concentrations compared to stimulated growth hormone (GH) in the evaluation of children treated for malignancy.
    Cicognani A; Cacciari E; Pession A; Pasini A; De Iasio R; Gennari M; Alvisi P; Pirazzoli P
    J Pediatr Endocrinol Metab; 1999; 12(5):629-38. PubMed ID: 10703534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth response to rhIGF-I 80 microg/kg twice daily in children with growth hormone insensitivity syndrome: relationship to severity of clinical phenotype.
    Azcona C; Preece MA; Rose SJ; Fraser N; Rappaport R; Ranke MB; Savage MO
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):787-92. PubMed ID: 10619985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility of insulin-like growth factor binding protein-3 in the evaluation and treatment of short children with suspected growth hormone deficiency.
    Hasegawa Y; Hasegawa T; Aso T; Kotoh S; Nose O; Ohyama Y; Araki K; Tanaka T; Saisyo S; Yokoya S
    Eur J Endocrinol; 1994 Jul; 131(1):27-32. PubMed ID: 7518726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
    Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum IGF-I and IGFBP-3 concentrations do not accurately predict growth hormone deficiency in children with brain tumours.
    Weinzimer SA; Homan SA; Ferry RJ; Moshang T
    Clin Endocrinol (Oxf); 1999 Sep; 51(3):339-45. PubMed ID: 10469014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone (GH) secretion in children with Noonan syndrome: frequently abnormal without consequences for growth or response to GH treatment.
    Noordam C; van der Burgt I; Sweep CG; Delemarre-van de Waal HA; Sengers RC; Otten BJ
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):53-9. PubMed ID: 11167926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.